Gene Transfer for Patients With Fanconi Anemia Complementation Group A (FANCA)
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Mar 2019
Price : $35 *
At a glance
- Drugs RP-L101 (Primary)
- Indications Fanconi's anaemia
- Focus Adverse reactions
- Acronyms FANCA
- 22 Mar 2019 Planned primary completion date changed from 31 Dec 2027 to 17 Jul 2032.
- 19 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated